Experiment 626746
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Allium sativum (LILIACEAE) |
| Citation | BORDIA,A: VERMA,SK: SRIVASTAVA,KC:. (1998). EFFECT OF GARLIC (ALLIUM SATIVUM) ON BLOOD LIPIDS, BLOOD SUGAR, FIBRINOGEN AND FIBRINOLYTIC ACTIVITY IN PATIENTS WITH CORONARY ARTERY DISEASE.. 58(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | THIRTY PATIENTS WITH CORONARY ARTERY DISEASE (CAD) WERE ADMINISTERED GARLIC (STUDY GROUP) WHILE ANOTHER 30 PATIENTS RECEIVED THE PLACEBO (CONTROL GROUP). VARIOUS RISK PARAMETERS WERE DETERMINED AT 1.5 AND 3 MONTHS OF GARLIC ADMINISTRATION. GARLIC, ADMINSTERED IN A DAILY DOSE OF 2 X 2 CAPSULES (EACH CAPSULE CONTAINING ETHYL ACETATE EXTRACT FROM 1 G PEELED AND CRUSHED RAW GARLIC), REDUCED SIGNIFICANTLY TOTAL SERUM CHOLESTEROL AND TRIGLYCERIDES, AND INCREASED SIGNIFICANTLY HDL- CHOLESTEROL AND FIBRINOLYTIC ACTIVITY. THERE WAS NO EFFECT ON THE FIBRINOGEN AND GLUCOSE LEVELS. IN VITRO EFFECTS OF THE GARLIC OIL ON PLATELET AGGREGATION (PAG) AND EICOSANOID METABOLISM WERE EXAMINED; IT INHIBITED PAG INDUCED BY SEVERAL PLATELET AGONISTS, AND ALSO PLATELET THROMBOXANE FORMATION. |
| Dose amount | 4.0 MG |
| Number | 3 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOAC EXT |
| Gender | GIVEN TO BOTH SEXES |